76 results match your criteria: "Centre Hospitalier de Haguenau[Affiliation]"

Objective: Silica is an environmental substance strongly linked with autoimmunity. The aim of this study was to assess the prevalence of antineutrophil cytoplasmic antibody (ANCA)-associated vasculitis (AAV), including granulomatosis with polyangiitis (GPA), microscopic polyangiitis (MPA), and renal limited vasculitis, in a northeastern region of France and to evaluate whether there was a geospatial association between the localization of quarries in the region and the prevalence of these AAVs.

Methods: Potential AAV patients were identified using 3 sources: hospital records, immunology laboratories, and the French National Health Insurance System.

View Article and Find Full Text PDF

Background: Although there is an apparent rapid and spontaneous recovery of left ventricular ejection fraction (LVEF) in patients with Takotsubo syndrome (TTS), recent studies have demonstrated a long-lasting functional impairment in those patients. The present study sought to evaluate the predictors of incomplete recovery following TTS and its impact on cardiovascular mortality.

Methods and results: Patients with TTS between 2008 and 2018 were retrospectively enrolled at 3 different institutions.

View Article and Find Full Text PDF

Expanding the clinical spectrum of STIP1 homology and U-box containing protein 1-associated ataxia.

J Neurol

May 2021

Service de Génétique Médicale, Hôpitaux de Brabois, CHRU de Nancy, Rue du Morvan, 54500, Vandoeuvre-lès-Nancy, France.

Background: STUB1 has been first associated with autosomal recessive (SCAR16, MIM# 615768) and later with dominant forms of ataxia (SCA48, MIM# 618093). Pathogenic variations in STUB1 are now considered a frequent cause of cerebellar ataxia.

Objective: We aimed to improve the clinical, radiological, and molecular delineation of SCAR16 and SCA48.

View Article and Find Full Text PDF

Pericardial effusion in patients with COVID-19: case series.

Eur Heart J Case Rep

October 2020

Division of Cardiovascular Medicine, Centre Hospitalier de Haguenau, 64 Avenue du Professeur Leriche, Haguenau, Alsace 67500, France.

Background: SARS-coronavirus-2 [coronavirus disease 2019 (COVID-19)] infection is a public health issue affecting millions of people. It started in Wuhan in China in December 2019 spreading rapidly worldwide.

Case Summary: Three patients aged 51-84 developed a pericarditis related to COVID-19, associated for two of them with a myocarditis.

View Article and Find Full Text PDF

Impact of residual inflammation on myocardial recovery and cardiovascular outcome in Takotsubo patients.

ESC Heart Fail

February 2021

Pôle d'Activité Médico-Chirurgicale Cardio-Vasculaire, Nouvel Hôpital Civil, Centre Hospitalier Universitaire, Université de Strasbourg, BP 426, Strasbourg, 67091, France.

Aims: Recent insights have emphasized the importance of myocardial and systemic inflammation in Takotsubo syndrome (TTS). In a large registry of unselected patients, we sought to evaluate whether residual high inflammatory response (RHIR) could impact cardiovascular outcome after TTS.

Methods And Results: Patients with TTS were retrospectively included between 2008 and 2018 in three general hospitals.

View Article and Find Full Text PDF
Article Synopsis
  • New-onset conduction abnormalities (CAs) following transcatheter aortic valve replacement (TAVR) can lead to increased hospitalizations and long-term mortality, but there are limited predictors for these outcomes.
  • A study involving 290 patients found that nearly half of those without prior left bundle branch block (LBBB) experienced new-onset LBBB or required a permanent pacemaker (PPM) after TAVR, with differences in membranous septal length and implantation depth identified as key predictors.
  • Patients with new CAs faced a significantly higher risk of adverse clinical events, highlighting the importance of assessing septal anatomy to potentially improve outcomes in future TAVR procedures.
View Article and Find Full Text PDF

[French national emergency department's crisis: The outcome of a growing gap between health resources and needs?].

Rev Med Interne

October 2020

Service d'Accueil des Urgences Adultes, Hôpitaux Universitaires de Strasbourg, 1 place de l'Hôpital, 67000 Strasbourg, France; UMR 1260, Fédération de médecine translationnelle de Strasbourg (FMTS), Université de Strasbourg, 4 Rue Kirschleger, 67000 Strasbourg, France.

Overcrowding in Emergency Departments is often considered as an outcome of insufficient access to hospital beds or primary care, therefore a potential lack of health resources. We sought to describe the quantitative evolution of health resources in the French health care system, in comparison with demographic and epidemiologic parameters that reflect health needs. Overall, in the last decade, parameters of capacity and human resources stagnated while activity and spending increased jointly, stimulated by ageing of the population and chronic diseases mostly.

View Article and Find Full Text PDF

[Early consultation after an acute decompensated heart failure episode].

Rev Infirm

September 2020

Centre hospitalier de Haguenau, 64, avenue du Professeur-Leriche, 67500 Haguenau, France. Electronic address:

Early consultation after acute decompensated heart failure supplements and reinforces the hospital care of patients with severe heart failure. Its aim is to prevent a new episode occurring during the period of increased vulnerability. It requires the active partnership of the patient and the complementary expertise of different professionals, specialised in heart failure and in therapeutic education : cardiologist, nurse and dietician.

View Article and Find Full Text PDF
Article Synopsis
  • Stroke is a significant concern for patients undergoing transcatheter aortic valve replacement (TAVR), and this study identifies predictors for these ischemic neurological events, focusing on von Willebrand factor (VWF) defects.
  • In a study of 565 TAVR patients, 3.7% experienced ischemic strokes or transient ischemic attacks (TIAs) within 30 days, with these events linked to major bleeding complications and prolonged closure time measurements (CT-ADP) post-procedure.
  • The findings highlight that major/life-threatening bleeding complications and a CT-ADP greater than 180 seconds are independent risk factors for ischemic strokes or TIAs in TAVR patients, suggesting VWF defects may
View Article and Find Full Text PDF

CERA conversion to darbepoetin alfa in 154 hemodialysis patients.

Int Urol Nephrol

October 2020

Dialysis Unit, AURAL, 5 Rue Henri Bergson, 67200, Strasbourg, France.

Purpose: Anemia is a common complication in dialysis patients, usually treated with erythropoietin (EPO). Among available EPOs and analogs, continuous erythropoietin receptor activator (CERA) and darbepoetin alfa (DA) are the only two agents with a long duration of action, although they have almost never been formally compared in terms of efficacy. We took advantage of an accidental disruption in CERA supply to study the effect of its replacement with DA in the same patients.

View Article and Find Full Text PDF

Neurologic and neuroimaging findings in patients with COVID-19: A retrospective multicenter study.

Neurology

September 2020

From the Hôpitaux Universitaires de Strasbourg (S.K., F.L., S.B., F.-D.A., T.W.), Service d'imagerie 2, Hôpital de Hautepierre; Engineering Science, Computer Science and Imaging Laboratory (S.K., N.M.), UMR 7357, University of Strasbourg-CNRS; Service de Neurologie (M. Anheim), Hôpitaux Universitaires de Strasbourg; Institut de Génétique et de Biologie Moléculaire et Cellulaire (M. Anheim), INSERM-U964/CNRS-UMR7104/Université de Strasbourg, Illkirch; Fédération de Médecine Translationnelle de Strasbourg (M. Anheim), Université de Strasbourg; Hôpitaux universitaires de Strasbourg (H.M., F.M., J.H.), Service de Médecine Intensive Réanimation, Nouvel Hôpital Civil; INSERM (French National Institute of Health and Medical Research) (H.M., F.M.), UMR 1260, Regenerative Nanomedicine, Fédération de Médecine Translationnelle de Strasbourg; Médecine Intensive-Réanimation (M.S., F.S.), Hôpital de Hautepierre, Hôpitaux Universitaires de Strasbourg; Service de Neuroradiologie (H.O., F.B., J.M.), Hôpitaux Civils de Colmar; Service d'Imagerie (A. Khalil, A.G.), Unité de Neuroradiologie, Assistance Publique-Hôpitaux de Paris, Hôpital Bichat Claude Bernard; Université Paris Diderot (A. Khalil), Paris; Service de Neurologie (S. Carré, C.L.), Centre Hospitalier de Haguenau; Service de Radiologie (M. Alleg), Centre Hospitalier de Haguenau; Service de Neuroradiologie, (E.S., R.A., F.Z.) Hôpital Central, CHU de Nancy; CHIC Unisanté (L.J., P.N., Y.T.M.), Hôpital Marie Madeleine, Forbach; Neuroimaging Department (G.H., J. Benzakoun, C.O., G. Boulouis, M.E.-G., B.K.), GHU Paris Psychiatrie et Neurosciences, Hôpital Sainte-Anne, Université de Paris, INSERM U1266, F-75014; CHU Rennes (J.-C.F., B.C.-N.), Department of Neuroradiology; CHU Rennes (A.M.), Medical Intensive Care Unit; Department of Neuroradiology (P.-O.C., F.R., P.T.), University Hospital of Dijon, Hôpital François Mitterrand; Service de Radiologie (C.B.), CHU de Saint-Etienne; Service de Réanimation (X.F.), CH de Roanne; Service de Neuroradiologie (G.F., S.S.), CHU de Limoges; Radiology Department (I.d.B., G. Bornet), Hôpital Privé d'Antony; Department of Diagnostic and Interventional Neuroradiology (H.D.), University Hospital, Nantes; Neuroradiology Department (J. Berge), CHU de Bordeaux; Service de Neuroradiologie (A. Kazémi), CHU de Lille; Assistance Publique Hôpitaux de Paris (N.P.), Service de Neuroradiologie, Hôpital Pitié-Salpêtrière; Sorbonne Université (N.P.), Univ Paris 06, UMR S 1127, CNRS UMR 7225, ICM, F-75013; Service de Neuroradiologie Diagnostique (A.L.), Foundation A. Rothschild Hospital, Paris; EA CHIMERE 7516 (J.-M.C.), Université de Picardie Jules Verne; Service de NeuroRadiologie, pôle Imagerie Médicale, Centre Hospitalo-Universitaire d'Amiens; Hôpitaux Universitaires de Strasbourg (P.-E.Z., M.M.), UCIEC, Pôle d'Imagerie, Strasbourg; Observatoire Français de la Sclérose en Plaques (J.-C.B.), Lyon; Nephrology and Transplantation Department (S. Caillard), Hôpitaux Universitaires de Strasbourg; Inserm UMR S1109 (S. Caillard), LabEx Transplantex, Fédération de Médecine Translationnelle de Strasbourg, Université de Strasbourg; Hôpitaux Universitaires de Strasbourg (O.C., P.M.M.), Service d'Anesthésie-Réanimation, Nouvel Hôpital Civil; Hôpitaux Universitaires de Strasbourg (S.F.-K.), Laboratoire de Virologie Médicale; Radiology Department (M.O.), Nouvel Hôpital Civil, Strasbourg University Hospital; CHU de Strasbourg (N.M.), Service de Santé Publique, GMRC, F-67091 Strasbourg; Immuno-Rhumatologie Moléculaire (S.F.-K., J.H.), INSERM UMR_S1109, LabEx TRANSPLANTEX, Centre de Recherche d'Immunologie et d'Hématologie, Faculté de Médecine, Fédération Hospitalo-Universitaire OMICARE, Fédération de Médecine Translationnelle de Strasbourg, Université de Strasbourg; MRI Center (F.C.), Centre Hospitalier Lyon Sud, Hospices Civils de Lyon; and Université Lyon 1 (F.C.), CREATIS-LRMN, CNRS/UMR/5220-INSERM U630, Villeurbanne, France.

Objective: To describe neuroimaging findings and to report the epidemiologic and clinical characteristics of patients with coronavirus disease 2019 (COVID-19) with neurologic manifestations.

Methods: In this retrospective multicenter study (11 hospitals), we included 64 patients with confirmed COVID-19 with neurologic manifestations who underwent a brain MRI.

Results: The cohort included 43 men (67%) and 21 women (33%); their median age was 66 (range 20-92) years.

View Article and Find Full Text PDF
Article Synopsis
  • Background: The study examines brain MRI abnormalities in patients with severe COVID-19 (SARS-CoV-2) and identifies potential neurological issues related to the virus.
  • Methods: Researchers analyzed data from 37 hospitalized patients who had neurological symptoms and abnormal brain MRIs between March and April 2020, excluding cases with ischemic strokes or unrelated chronic lesions.
  • Results: The patient cohort, primarily older men, exhibited various neurological symptoms, with MRI findings showing significant abnormalities in brain regions including the medial temporal lobe and evidence of microhemorrhages, suggesting COVID-19's impact on brain structure.
View Article and Find Full Text PDF

Thrombocytopenia in the Course of COVID-19 Infection.

Eur J Case Rep Intern Med

May 2020

Service de Médecine Interne, Diabète et Maladies Métaboliques, Hôpitaux Universitaires de Strasboug, Strasbourg France.

Unlabelled: We report three cases of severe thrombocytopenia during COVID-19 infection associated with either cutaneous purpura or mucosal bleeding. The initial investigations ruled out other causes of thrombocytopenia. Two of the patients were treated with intravenous immunoglobulins and eltrombopag, while the third recovered spontaneously.

View Article and Find Full Text PDF

COVID-19 and Inflammatory Bowel Disease: Questions on Incidence, Severity, and Impact of Treatment?

Clin Gastroenterol Hepatol

October 2020

Service d'Hépato-Gastroentérologie et d'Assistance Nutritive, HUS, Hôpital de Hautepierre, Strasbourg, France; INSERM U1113 IRFAC (Interface de Recherche, Fondamentale et Appliquée en Cancérologie), Université de Strasbourg, Faculté de Médecine, Strasbourg, France; Institut Hospitalo-Universitaire de Strasbourg, HUS, Strasbourg, France.

View Article and Find Full Text PDF
Article Synopsis
  • The study aimed to assess the effectiveness of the PRADO-IC program in reducing re-hospitalizations due to chronic heart failure (HF) among patients in the Bas-Rhin region of France.
  • It included 91 patients aged around 79 years, evaluating their hospital readmissions at intervals of 30 days, 6 months, and 1 year post-enrollment in the program.
  • The results indicated a significant decrease in both the frequency of HF-related hospitalizations and the average length of stay, suggesting that the PRADO-IC program successfully improved patient outcomes.
View Article and Find Full Text PDF
Article Synopsis
  • The study focused on assessing the success of hepatitis B vaccination in patients with chronic kidney disease (CKD) prior to dialysis, analyzing clinical and biological factors that influence protection rates.
  • Out of 170 non-dialyzed CKD patients vaccinated, 50.6% achieved protective antibody levels, with a Bayesian model proving more effective than logistic regression in predicting vaccination success based on various health parameters.
  • Key factors affecting vaccination success included age, kidney function (eGFR), nutritional status (protidemia and albuminemia), and previous vaccination history, highlighting the importance of these elements in improving vaccine outcomes for CKD patients.
View Article and Find Full Text PDF

Background: Bifurcation lesions represent 15-20% of all patients undergoing a percutaneous coronary intervention (PCI) for coronary artery disease. The provisional 1-stent stenting strategy is the preferred strategy to treat bifurcation lesions. Other strategies used to treat bifurcation lesions include 2-stent complex stenting strategies and the Tryton Side Branch Stent (TSB)-a dedicated side-branch stent for bifurcation lesions, which gained FDA approval in March 2017.

View Article and Find Full Text PDF

Does Transcatheter Aortic Valve Replacement Modulate the Kinetic of Superoxide Anion Generation?

Antioxid Redox Signal

August 2019

1 Pôle d'Activité Médico-Chirurgicale Cardio-Vasculaire, Nouvel Hôpital Civil, Centre Hospitalier Universitaire, Université de Strasbourg, Strasbourg, France.

Reactive oxygen species (ROS) are central bioenergetic markers linked to aortic stenosis (AS) development and severity. We sought to evaluate the time course and impact of ROS assessed by plasmatic superoxide anion (SA) among patients undergoing transcatheter aortic valve replacement (TAVR). Among 106 patients, SA significantly decreased after TAVR.

View Article and Find Full Text PDF

Primary Hemostatic Disorders and Late Major Bleeding After Transcatheter Aortic Valve Replacement.

J Am Coll Cardiol

October 2018

Université de Strasbourg, Pôle d'Activité Médico-Chirurgicale Cardio-Vasculaire, Nouvel Hôpital Civil, Centre Hospitalier Universitaire, Strasbourg, France; UMR 1260 INSERM Nanomédecine Régénérative, Université de Strasbourg, Strasbourg, France. Electronic address:

Background: Periprocedural and late (>30 days) bleedings represent major complications after transcatheter aortic valve replacement and have been identified as potential areas for improved patient care.

Objectives: The authors sought to evaluate the impact of ongoing primary hemostasis disorders on late major/life-threatening bleeding complications (MLBCs).

Methods: Bleedings were assessed according to the VARC-2 (Valve Academic Research Consortium-2) criteria.

View Article and Find Full Text PDF

Objectives: The aim of this study was to identify using implantable loop recorder (ILR) monitoring the mechanisms leading to sudden death (SD) in patients undergoing hemodialysis (HD).

Background: SD accounts for 11% to 25% of death in HD patients.

Methods: Continuous rhythm monitoring was performed using the remote monitoring capability of the ILR device in patients undergoing HD at 8 centers.

View Article and Find Full Text PDF

CT-ADP Point-of-Care Assay Predicts 30-Day Paravalvular Aortic Regurgitation and Bleeding Events following Transcatheter Aortic Valve Replacement.

Thromb Haemost

May 2018

Pôle d'Activité Médico-Chirurgicale Cardio-Vasculaire, Nouvel Hôpital Civil, Centre Hospitalier Universitaire, Université de Strasbourg, Strasbourg, France.

Article Synopsis
  • Paravalvular aortic regurgitation (PVAR) is a common issue after transcatheter aortic valve replacement (TAVR), linked to complications like bleeding due to altered blood flow dynamics.
  • This study found that an increase in closure time with adenosine diphosphate (CT-ADP) post-procedure can indicate significant PVAR and potential bleeding risks at 30 days follow-up.
  • Specifically, a CT-ADP measurement over 180 seconds was shown to be an independent predictor of both significant PVAR and major/life-threatening bleeding complications in patients.
View Article and Find Full Text PDF